Advisor Group Holdings, Inc. Tyme Technologies, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 04, 2022	SELL	$0.28 - $0.68 $1,694 - $4,114	-6,050 Reduced 73.33%	2,200 $1,000
Q3 2021 Nov 05, 2021	BUY	$0.99 - $1.38 $2,970 - $4,140	3,000 Added 57.14%	8,250 $9,000
Q2 2021 Aug 02, 2021	BUY	$1.14 - $1.87 $285 - $467	250 Added 5.0%	5,250 $6,000
Q1 2021 May 13, 2021	SELL	$1.34 - $3.53 $27,403 - $72,188	-20,450 Reduced 80.35%	5,000 $9,000
Q1 2020 May 18, 2020	BUY	$0.9 - $1.95 $22,905 - $49,627	25,450 New	25,450 $28,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.